Posts With Tag SUBLOCADE

Showing 1 - 2 of 2 Posts

Indivior PLC's Form 6-K: FDA Approves SUBLOCADE Label Changes - Feb 2025

•

Form 6-K

•

2025-02-24

Last updated: 2 months ago

Indivior PLC's Form 6-K: FDA Approves SUBLOCADE Label Changes - Feb 2025

Indivior PLC reports FDA approval for SUBLOCADE label changes, enhancing marketability and compliance. Key insights on regulatory impact and investor confidence.

Indivior PLC FDA Approval SUBLOCADE Pharmaceuticals Regulatory Compliance

Indivior PLC's 6-K Report: Delayed FDA Approval for SUBLOCADE Label Changes

•

Form 6-K

•

2025-02-12

Last updated: 3 months ago

Indivior PLC's 6-K Report: Delayed FDA Approval for SUBLOCADE Label Changes

This report details Indivior PLC's Form 6-K regarding the delayed FDA approval of SUBLOCADE label changes, impacting investor sentiment and market outlook.

Indivior PLC FDA Approval SUBLOCADE Pharmaceuticals Investor Relations